Announcing the results of the 2026 INFORMS Board of Directors election and the new board for 2027.
INFORMS has named 12 distinguished leaders as the 2026 class of INFORMS Fellows, one of the highest honors in the profession.
Most medical devices do not hit the market through rigorous safety testing but by being deemed similar enough to something already approved—the “predicate” device through a mechanism known as the FDA’s 510(k) pathway. But similar is not a synonym for safe. While the assumption may be that substantial equivalence is a reasonable stand-in for a safety review, a share of devices cleared with this method still get recalled, and the FDA spends valuable time reviewing devices the same way, regardless of how risky it is on paper.
An audio journey of how data and analytics save lives, save money and solve problems.
Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
Neuralink, Elon Musk's brain-computer-interface company, is looking to hire manufacturing technicians and microfabrication specialists.
Tariffs could raise the cost of medical care and prescription drugs for people in the U.S.
Companies around the world are increasingly committed to cutting their greenhouse gas emissions to slow and ultimately reverse climate change.
Businesses plan to stockpile, raise prices and accelerate shift to manufacturing elsewhere
NEW ORLEANS, La. (KPEL News) - Louisiana intersections might one day look different, with the familiar red, yellow, and green lights potentially gaining a new color: white.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine